Science ❯ Biotechnology

Genetic Engineering

CRISPR Technology mRNA Technology Gene Editing De-extinction Xenotransplantation Gene Therapy Cloning Microbiology Genetically Modified Organisms Organ Transplantation RNA Technology Therapeutic Applications New Genomic Techniques Vaccine Technology CRISPR Species Resurrection Animal Models Cell Therapy Species Revival Genome Editing Animal Genetics CRISPR Applications Plant Genetic Engineering Crispr Technology Microbial Therapy DNA Applications Gene Delivery Systems Crop Modification Crop Improvement Human Enhancement Insect Biotechnology Conservation Biology Gene Modification Xenotransplantation Research Synthetic Biology Organ Modification Plant Biotechnology Stem Cell Research Genetic Modification Microbial Engineering mRNA Vaccines Vaccine Development Vaccinology Therapeutic Proteins Recombinant Bacteria Gene Drive Technology Oncolytic Viruses Hybrid Technology Functional Genomics Agricultural Biotechnology Codon Compression Mitochondrial Donation Treatment Cancer Therapies mRNA Research Cell Reprogramming Yeast Engineering Bioluminescent Plants Organ Replacement Bioinsecticides Therapeutics Organ Engineering Genomic Sequencing Plant Genetics New Technologies Avian Genetics DNA Editing Techniques RNA Technologies Viral Therapy New Breeding Techniques Pharmaceutical Development Enzyme Technology GMOs Genomic Techniques Medical Applications Organ Transplants Cancer Research Fungal Biotechnology Cell Biology Food Technology Crop Science Plant Biology Machine Learning mRNA Systems Microbial Production Biological Manufacturing Crop Protection Immunotherapy Transgenic Animals Gene Discovery Xenomorphs Codon Reassignment Plant Traits Protein Production Genetic Medicines Forestry Cellular Engineering Plant-Animal Hybridization Cell Engineering Gain-of-Function Research Crispr/Cas Technology

DNA-Origami Vaccine Scaffold Boosts HIV Broadly Neutralizing Antibody Precursors in Mice

By remaining immunologically silent, the design cut off-target B cell reactions compared with a protein nanoparticle.

UAE Backs Colossal’s BioVault at Dubai Museum to Bank Genetic Material From Imperiled Species

Genentech Licenses SanegeneBio RNAi Program in Deal Worth Up to $1.7 Billion

States Curb Medicaid Coverage as First GLP‑1 Weight‑Loss Pill Debuts and Cash Prices Fall

Contrarius Global Equity Fund Q3 Letter Posts 30.9% Return, Spotlights Media Re‑rating Plays and CRISPR Economics

Colossal Foundation Hits $100 Million to Scale Biotech Conservation

Mount Sinai's V2P AI Predicts Disease Type From Genetic Mutations

CRISPR Yields Compact Goldenberry Lines Deemed Ready for Production

UK Trial’s Base-Edited Off-the-Shelf CAR T Cells Deliver Durable Remissions in T-Cell Leukemia

EU Strikes Provisional Deal to Ease Rules for Gene-Edited Crops

CRISPR-Edited Fungus Boosts Mycoprotein Efficiency, Cuts Modeled Emissions

CRISPR-Edited Fungus Delivers Faster, Lower-Impact Mycoprotein

Tom Brady’s Dog Clone Puts New Attention on Colossal’s Viagen Deal and the Business of Pet Cloning

Colossal Biosciences Acquires ViaGen to Bolster Cloning for De‑Extinction

Mass General Removes Pig Kidney After Record 271 Days in New Hampshire Patient

mRNA COVID Vaccines Linked to Longer Survival With Cancer Immunotherapy, Nature Study Reports

First Therapeutic Pig-to-Human Liver Transplant Works for Weeks in Living Patient

First Human Test of Enzyme-Converted Kidney Points to Path for Universal-Type Transplants

MAHA Drops Glyphosate From New Strategy After Farm Groups Press Case

mRNA Allergy Vaccine Prevents Severe Reactions in Mice